Edesa Biotech Inc expected to post a loss of 69 cents a share - Earnings Preview

Edesa Biotech

08/05/2024 24:28

* Edesa Biotech Inc  EDSA.OQ   EDSA.O  is expected to show
no
change in quarterly revenue when it reports  results on May 9
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Edesa Biotech Inc is for
a
loss of 69 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $21.00​, above​ its last closing price of $4.52. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -1.41       -1.21      -0.54     Beat    55.4
 Sep. 30 2023  -0.71       -0.71      -0.60     Beat    15.1
 Jun. 30 2023  -1.10       -1.21      -0.70     Beat    42.3​
 Mar. 31 2023  -0.98       -1.21      -0.84     Beat    30.8
 ​​Jan.        -1.32       -1.33      -0.91     Beat    31.6
 1 0001                                                 
 Sep. 30 2022              -2.76      -0.14     Beat    94.9​
 Jun. 30 2022  -3.01       -3.01      -2.59     Beat    14
 Mar. 31 2022  -2.38       -2.57      -2.31     Beat    10
 This summary was machine generated May 7 at 23:28 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)